We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genflow Biosciences Plc | LSE:GENF | London | Ordinary Share | GB00BP2C3V08 | ORD GBP0.0003 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.275 | 18.64% | 1.75 | 1.70 | 1.80 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1.75 | 1.475 | 1.475 | 1,720,231 | 16:29:03 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 169k | -1.63M | -0.0047 | -3.72 | 5.16M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/10/2024 | 10:49 | ALNC |  Genflow Biosciences secures EUR4 million for liver disease treatment |
| 22/10/2024 | 06:00 | UK RNS | Genflow Biosciences PLC Genflow Secures Non-Dilutive Financial Support |
| 30/9/2024 | 06:00 | UK RNS | Genflow Biosciences PLC Half-year Report |
| 27/6/2024 | 19:23 | ALNC | EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens |
| 27/6/2024 | 12:30 | UK RNS | Genflow Biosciences PLC Result of AGM |
| 27/6/2024 | 06:00 | UK RNS | Genflow Biosciences PLC Strengthening of Pre-Clinical Efforts |
| 12/6/2024 | 15:41 | ALNC | EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant |
| 12/6/2024 | 06:00 | UK RNS | Genflow Biosciences PLC Receipt of Grant Funding |
| 03/6/2024 | 06:00 | UK RNS | Genflow Biosciences PLC Notice of AGM |
| 30/5/2024 | 11:03 | ALNC | Genflow Biosciences receives 50% of grant for sarcopenia project |
1 Year Genflow Biosciences Chart |
Intraday Genflow Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
